VIEWS: 10 PAGES: 2 CATEGORY: Press Releases POSTED ON: 1/3/2013
TAIPEI, Taiwan--(BUSINESS WIRE)--PharmaEngine, Inc. (TWO: 4162) announced today the execution of a Collaboration and Research Agreement with Guangzhou BeBetter Medicine Technology Co., Ltd. (BeBetter). The two companies will collaborate to design, synthesize and develop new chemical entities (“drug candidates”) against predefined targets in oncology. This collaboration opens a new chapter for partnership between Taiwan and China in searching for novel anti-cancer drugs. Under the terms of the ag a
"PharmaEngine and Guangzhou BeBetter Medicine Technology Signed a Collaboration and Research Agreement"